5.45 USD
▼+0.40-5.38%
2026-08-03
市值
$75.72M
市盈率
—
EPS
-0.09
股息率
—
52 周区间
5.22 – 8.74
成交量
18.69K
Beta
0.41
目标价
—
52W 低 5.2252W 高 8.74
价格走势
公司简介
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers...